
Ather Energy IPO Date, Review, Price, Allotment Details
Ather Energy IPO open date is April 28, 2025 and the IPO will close on April 30, 2025. Ather Energy IPO is a Book Built Issue. The company to raise

Ather Energy IPO open date is April 28, 2025 and the IPO will close on April 30, 2025. Ather Energy IPO is a Book Built Issue. The company to raise

Iware Supplychain Services IPO open date is April 28, 2025 and the IPO will close on April 30, 2025. Iware Supplychain Services IPO is a Fixed Price Issue. The company

BMW Ventures IPO date is not announced yet. BMW Ventures is a book built issue and have plan to raise around ā¹[.] crores via IPO that comprises fresh issue of

Upcoming IPOs This week, the Indian primary market has been vibrating as investors eagerly anticipate an abundance of new initial public offerings (IPOs) and listings. 5 companies will be listed

The Ather Energy IPO allotment status is available as the basis of allotment is finalized now. The Ather Energy IPO subscription was ended on April 30, 2025, Wednesday.
The investors

The Iware Supplychain Services IPO allotment status is available as the basis of allotment is finalized now. The Iware Supplychain Services IPO subscription was ended on April 30, 2025, Wednesday.

Kenrik Industries IPO subscribed over 0.77x on its third day of subscription, wherein QIB subscribed 0x, NII subscribed 0.6x, and RII subscribed 1.48x.

Wagons Learning IPO subscribed over 0.02x on its First day of subscription, wherein QIB subscribed 0x, NII subscribed 0.01x, and RII subscribed 0.04x.

Arunaya Organics IPO subscribed over 2.53x on its Last day of subscription, wherein QIB subscribed 1.01x, NII subscribed 1.49x, and RII subscribed 4.33x.

Arunaya Organics IPO subscription status started on Tuesday April 29, 2025 and will close on May 2, 2025. Arunaya Organics IPO to raise around ā¹33.99 crores via IPO. The

Canara HSBC Life IPO filed preliminary papers with the SEBI for an IPO, consisting of OFS of 23.7 crore equity shares with ā¹10 shares each.

Corona Remedies, one of Indiaās leading pharmaceutical formulation companies backed by ChrysCapital, has submitted its DRHP to the market regulator SEBI to raise funds of ā¹800 crore through an Initial